Tidal Breathing Flow-Volume (TBFV) loops in bronchiolitis in infancy: the effect of albuterol

ISRCTN ISRCTN47364493
DOI https://doi.org/10.1186/ISRCTN47364493
Secondary identifying numbers N/A
Submission date
26/02/2002
Registration date
26/02/2002
Last edited
06/09/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Balagangadhar R Totapally
Scientific

Division of Critical Care Medicine
Miami Children's Hospital
3100 SW 62nd Avenue
Miami
FL 33155
United States of America

Email bala.totapally@mch.com

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesTo evaluate the effect of nebulized albuterol on tidal breathing flow-volume loops in infants with bronchiolitis due to Respiratory Syncytial Virus (RSV).
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedRespiratory Syncytial Virus (RSV) bronchiolitis
InterventionCompared the effect of nebulized albuterol versus nebulized saline on various parameters of tidal breathing flow-volume loops
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Albuterol
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2000
Completion date01/01/2001

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants20
Key inclusion criteriaOne month to one year infants with Respiratory Syncytial Virus (RSV) positive bronchiolitis
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2000
Date of final enrolment01/01/2001

Locations

Countries of recruitment

  • United States of America

Study participating centre

Division of Critical Care Medicine
Miami
FL 33155
United States of America

Sponsor information

Hurley Medical Center (USA)
Hospital/treatment centre

One Hurley Plaza
Flint
MI 48503
United States of America

ROR logo "ROR" https://ror.org/034npj057

Funders

Funder type

Not defined

Not provided at time of registration

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/04/2002 Yes No